Back

D-Ribose

supporting cellular energy production

Evidence · Grade C
Human trial evidenceTraditional useInteraction risk

D-Ribose is a natural sugar crucial for cellular energy production (ATP) and genetic material, with supplementation explored for conditions involving energy depletion, though evidence is limited.

Last reviewed June 17, 2026 · AI-assisted, human-reviewed
D-Ribose is a naturally occurring five-carbon sugar that is a fundamental component of adenosine triphosphate (ATP), the primary energy molecule in the body. In heart failure, the heart's ability to produce sufficient energy is compromised, and D-Ribose supplementation aims to restore ATP levels and improve cardiac function.

Quick answer

What it is: D-Ribose is a naturally occurring five-carbon sugar that is a fundamental component of adenosine triphosphate (ATP), the primary energy molecule in the body.

May support:Heart Failure, Chronic Fatigue, Chronic Fatigue Syndrome

Evidence:Evidence · Grade C

Evidence Summary

Evidence · Grade C

As no specific PubMed studies were provided, the evidence grade for D-Ribose in the listed ailments is considered preliminary. The rationale for its use is primarily based on its known biochemical role in ATP synthesis and theoretical considerations regarding energy metabolism. Any claims regarding efficacy would currently be speculative without direct clinical trial data.

Last reviewed · Jun 2026

Have you tried D-Ribose?

Vote in 5 seconds. Add details if you want.

Your experience for Heart Failure:

Commonly Combined With

Other remedies frequently used alongside this one — from curated relationships, community reports, and shared protocols.

Community signal breakdown

Where this remedy is being discussed across the web and community.

People Like Me insights

As more members share outcomes, RemedyAtlas will show which remedies helped people with similar conditions, symptoms, goals, and lab patterns.

Community Discussions

What people say about D-Ribose

Search on Reddit →

Latest News

Latest news on D-Ribose

More on Google News →

Health Videos

Health videos on D-Ribose

More on YouTube

Why It Works

D-Ribose is a rate-limiting substrate in the de novo synthesis of adenine nucleotides, including ATP. By providing exogenous D-Ribose, the heart muscle can more efficiently replenish its energy stores, which are often depleted in conditions like heart failure. This improved energy availability can enhance myocardial contractility and overall cardiac performance.

How it works in more detail

D-Ribose is a key component of the pentose phosphate pathway, which is essential for the synthesis of purine nucleotides, including adenosine. Adenosine is then phosphorylated to form adenosine monophosphate (AMP), adenosine diphosphate (ADP), and ultimately adenosine triphosphate (ATP). ATP is the primary molecule for energy transfer within cells. In situations of high energy demand or metabolic stress, such as ischemia or intense exercise, ATP can be depleted. D-Ribose supplementation is hypothesized to bypass rate-limiting steps in the de novo synthesis of purines, thereby accelerating the replenishment of ATP and other high-energy phosphate compounds. This mechanism is thought to be particularly relevant in tissues with high energy turnover, such as cardiac and skeletal muscle.

How to use

Always consult a qualified clinician.

Editorial guidance

Suggested dosage
5-10 grams orally, 2-3 times daily, or as recommended by a healthcare professional.
Research dosage range
Research dosages have varied, but some studies have used 5-15 grams per day, often divided.
Typical onset
Effects, if any, may not be immediate and could require consistent supplementation over several days to weeks, particularly for conditions related to energy replenishment.
Typical forms
powder, capsule
Quality markers
Look for products labeled as 'pure D-Ribose' or 'pharmaceutical grade' from reputable manufacturers. Third-party testing for purity and absence of contaminants can provide additional assurance.
Medication interactions
  • Antidiabetic medications (may enhance blood sugar lowering effects)
Avoid if
  • Diabetic (use with caution and monitor blood sugar)
  • Pregnant or breastfeeding (lack of sufficient safety data)

Community tips

No community tips yet — be the first to share what worked for you.

Suggested dosage

5-10 grams orally, 2-3 times daily, or as recommended by a healthcare professional.

General guidance — discuss specifics with a clinician.

Active medicinal compounds

D-Ribose (a monosaccharide)

Traditional use

D-Ribose is a fundamental biochemical compound and does not have a history of traditional use as a standalone remedy in herbal medicine or traditional healing systems.

Safety

Safety warnings

Generally well-tolerated, but high doses may cause mild gastrointestinal upset, diarrhea, or temporary drops in blood sugar. Individuals with diabetes should monitor blood glucose closely.

Avoid if

  • Diabetic (use with caution and monitor blood sugar)
  • Pregnant or breastfeeding (lack of sufficient safety data)

Medication interactions

  • Antidiabetic medications (may enhance blood sugar lowering effects)

Reported side effects

  • Mild gastrointestinal upset
  • Diarrhea (at high doses)
  • Hypoglycemia (in susceptible individuals or with high doses)
  • Headache

General guidance — discuss specifics with a clinician.

Evidence ecosystem

Scientific literature, clinical guidance, government sources, ongoing research, traditional use, and lived experience — grouped by source type and quality.

Overall grade (C)

As no specific PubMed studies were provided, the evidence grade for D-Ribose in the listed ailments is considered preliminary. The rationale for its use is primarily based on its known biochemical role in ATP synthesis and theoretical considerations regarding energy metabolism. Any claims regarding efficacy would currently be speculative without direct clinical trial data.

Clinical Trial Registries(1)

Registered ongoing or completed trials (ClinicalTrials.gov).

Moderate Quality
  • Effects of 2-Aticyto Complex and D-Ribose on Pain, Symptoms, and Clinical Course in Patients With Fibromyalgia Syndrome

    n=200 · NCT07495943 · NOT_YET_RECRUITING · NOT_YET_RECRUITING

    This multicenter, randomized, double-blind, placebo-controlled study will evaluate whether an oral supplement containing 2-Aticyto Complex and D-ribose (FibroThol), added to ongoing standard medical treatment, improves pain, symptoms, and clinical course in adults with fibromyalgia syndrome. Eligible participants are adults aged 18 to 65 years who have had fibromyalgia for at least 1 year and have been receiving pregabalin and/or duloxetine for at least 3 months. Participants will be randomly assigned to receive either FibroThol or placebo, administered as 15 mL three times daily for 4 weeks, while continuing their existing treatment. Follow-up assessments will be performed at baseline, week 2, and week 4 using patient-reported symptom and function measures. The study aims to determine whether this supportive supplement provides additional benefit compared with placebo in patients with persistent symptoms despite standard therapy.

    Clinical TrialClinicalTrials.govModerate Quality

Limitations: A significant limitation is the absence of specific PubMed studies for review, meaning there is no direct scientific evidence from clinical trials to support efficacy for the listed ailments. Without such studies, it is impossible to assess study design, sample size, methodology, or outcomes, which are critical for determining the strength and reliability of any potential benefits. Therefore, any potential benefits remain unproven in a clinical context.

This page is educational. Statements use phrases like "may support" and "has been studied for"because no remedy here is approved to cure, treat, or reverse any condition. Discussion happens on the ailment pages — community statistics here are derived from those reports. Always consult a qualified clinician.

Tried D-Ribose?

Help others see what actually works.